Professional Documents
Culture Documents
It is believed that one of the causes of Alzheimer’s disease (AD) is the deficit in
neuronal acetylcholine function, especially in the hippocampus. Indeed, the clinical picture of
patients who has a toxic level of anticholinergic medications is relatively similar to dementia.
Therefore, to improve AD symptoms, acetylcholine (Ach) level should be boosted up.
One of the ways to improve Ach function is to block the enzyme acetylcholinesterase
that breaks down acetylcholine. This enzyme is most found in the hippocampus. The first
medication found to improve dementia is Tacrine. It is no longer used as first line of
treatment because of intolerable adverse reactions. The 3 most commonly used
anticholinesterase medications are: Donepezil/Aricept (FDA approved in 1997),
Rivastigmine/Exelon (2000), and Galantamine/Reminyl (2001). The most common side
effect of these medications is gastrointestinal disturbances (nausea, vomiting, diarrhea, loss
of appetite). They should be titrated up slowly and taken with meal to delay the absorption.
Rapid absorption may increase side effects. Some patients report that ginger improves GI
side effects.
Aricept is taken once a day while the other medications should be taken bid. The dose
range of Aricept is 5 to 10 mg/day, with better efficacy at the higher dose range. In term of
improving compliance, once a day dosage is better than bid dosage, especially in this
particular population prone to forgetfulness. In addition, it is not uncommon for the elderly
patients to receive multiple medications for different illnesses. Therefore, the simpler the
medication regimen, the better is compliance. Aricept should be taken in the morning if it
causes nightmares. Usually, patients should start with 5mg/d for a month then the dose can be
titrated up to 10mg/d.
Nemanda is given bid. It is started with 5mg/d and titrated up weekly in 5mg
increments to a maintenance dose of 10mg bid. It can be taken with or without food. In
general, this medication is well tolerated. Dizziness is the most common symptom and is
reported as mild in clinical trials.